Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

Abstract

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms. Status: ENROLLING_BY_INVITATION Conditions: B-cell Lymphoma; Chronic Lymphocytic Leukemia; Hematologic Malignancy; AML (Acute Myelogenous Leukemia); Prostate Cancer Interventions: UniCAR02-T (IMP) With Targeting Module TM123; UniCAR02-T-pPSMA; Allo-RevCAR01- T with Targeting Module R-TM123; Allo-QuadCAR01-T

Keywords

Sources